Dysregulated Recruitment of the Histone Methyltransferase EZH2 to the Class II Transactivator (CIITA) Promoter IV in Breast Cancer Cells-Reference-Cited by-同舟云学术

Dysregulated Recruitment of the Histone Methyltransferase EZH2 to the Class II Transactivator (CIITA) Promoter IV in Breast Cancer Cells

Published:2012-04-26 Issue:4 Volume:7 Page:e36013
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Truax Agnieszka D.,Thakkar Meghna,Greer Susanna F.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference72 articles.

1. The class II molecules of the human and murine major histocompatibility complex.;JF Kaufman;Cell,1984

2. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.;CH Chang;J Exp Med,1994

3. Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virus.;P Langlade-Demoyen;Eur J Immunol,2003

4. Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.;PD Greenberg;J Exp Med,1981

5. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.;H Fujiwara;J Immunol,1984

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic genes model of breast cancer drug resistance based on single-cell sequencing analysis and transcriptome analysis;Clinical and Experimental Medicine;2024-05-25

2. EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusion;2024-05-17

3. The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation;Cancer Gene Therapy;2024-02-13

4. Targeting the chromatin structural changes of antitumor immunity;Journal of Pharmaceutical Analysis;2023-11

5. Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance;Journal for ImmunoTherapy of Cancer;2023-11